Is GL a Buy? What to Consider in 2026
Last updated July 2026
Short answer
The bull case for GL (GL) rests on Premium growth across agency divisions: Life and health premium continue to grow, with American Income Life and Liberty National posting net sales gains and rising underwriting margins in recent quarters. Revenue (TTM) is ~$6.0B. If you believe that thesis holds, the real questions become position sizing and overlap, not timing. The main risk to that view: Reputational and legal exposure is the defining risk: the 2024 Fuzzy Panda short report alleged systemic insurance fraud (policies for deceased or fictitious people, forged signatures, unauthorized withdrawals) concentrated in agents at American Income Life, and shareholder and derivative lawsuits alleging the company misled investors remain ongoing even after the DOJ probe closed without action. Whether GL is a buy comes down to whether you believe the thesis. This is informational, not a recommendation, and Walnut is not an investment adviser.
Globe Life Inc. is a Texas-based insurance holding company (formerly Torchmark) that underwrites individual life insurance and supplemental health insurance aimed at lower-to-middle-income American families. It sells through captive and exclusive agency channels under subsidiaries including American Income Life, Liberty National, Family Heritage, United American, and the direct-to-consumer Globe Life brand, and reports across life, health, and investment segments. The model emphasizes a large in-force book of small-face-amount policies with high persistency, which produces recurring premium and a sizable investment portfolio. The investment picture centers on consistent premium growth, mid-to-high-teens return on equity, and aggressive share repurchases that compound book value per share. Recent results show revenue and operating earnings growing at mid-single-digit to low-double-digit rates, and management raised full-year 2026 earnings guidance. The main counterweight is reputational and legal: in April 2024 short-seller Fuzzy Panda alleged widespread insurance fraud tied to agents at American Income Life, which halved the stock, and while the US Attorney's Office closed its investigation in mid-2025 without enforcement action, shareholder litigation and ongoing scrutiny of the agency distribution model remain part of the story.
What's the case for buying GL?
1. Premium growth across agency divisions
Life and health premium continue to grow, with American Income Life and Liberty National posting net sales gains and rising underwriting margins in recent quarters. Health premium revenue grew roughly 13 percent year over year in early 2026. The captive agency model drives new business volume that feeds the recurring in-force book.
2. High return on equity and book-value compounding
Globe Life posts return on equity near the high teens (around 17.9 percent for the quarter ended March 2026) and grew book value per share about 19 percent over the prior year to roughly $77. Steady profitability plus retained earnings compound intrinsic value over time.
3. Share repurchases and dividend growth
The company is a persistent buyer of its own stock, repurchasing roughly 1.4 million shares for about $205 million in a single recent quarter, which lifts per-share earnings. It also has a multi-decade record of annual dividend increases, though the yield is modest at under 1 percent because the payout ratio is low.
4. Resolution of the DOJ overhang
The US Attorney's Office for the Western District of Pennsylvania closed its investigation into Globe Life and American Income Life in July 2025 with no enforcement action. Removing that specific regulatory cloud allowed the stock to recover meaningfully from its 2024 lows and prompted some analyst rating upgrades.
What are the risks to GL?
Reputational and legal exposure is the defining risk: the 2024 Fuzzy Panda short report alleged systemic insurance fraud (policies for deceased or fictitious people, forged signatures, unauthorized withdrawals) concentrated in agents at American Income Life, and shareholder and derivative lawsuits alleging the company misled investors remain ongoing even after the DOJ probe closed without action. The captive and exclusive agency distribution model concentrates sales in third-party agencies whose conduct the company must police, creating continued regulatory and headline risk. As a life and health insurer, GL is also exposed to interest-rate and credit risk on its large investment portfolio, mortality and morbidity experience, and reserve-adequacy assumptions. Any renewed regulatory inquiry or adverse litigation outcome could pressure the stock, and the middle-income customer base can be sensitive to economic stress and policy lapse.
How is GL valued? (as of JULY 2026)
Snapshot for GL as of July 2026, sourced from Yahoo Finance and may be delayed. Valuation figures move with price and earnings; verify the current numbers with your broker before deciding.
- Revenue (TTM): ~$6.0B
- Market cap: ~$13.9B
- Diluted EPS (2025): ~$14.07
- 2026 EPS guidance: ~$15.40 to $15.90
- Trailing P/E: ~11x
- Dividend yield: ~0.9%
GL trades at a low-teens trailing price-to-earnings multiple, well below the broad market, reflecting both its steady insurance-underwriting profile and the reputational discount lingering from the 2024 allegations. Return on equity in the high teens and book value per share near $77 support a valuation that leans on consistent earnings and buybacks rather than high growth. Figures are approximate and drawn from 2025 results and 2026 quarterly reporting.
How do you decide if GL is a buy?
Rather than asking whether GL is a buy in the abstract, it tends to help to answer four questions:
- Thesis: do you believe the case above, and is it still true today?
- Time horizon: a single stock can be volatile, so a longer horizon absorbs more of the swings.
- Position sizing: a thesis can be right and the sizing still wrong; decide how much of your portfolio one name should be.
- Overlap: check whether you already hold GL indirectly through an index or sector ETF before adding more.
For the full picture, see the GL stock guide (what the company does, the ETFs that hold it, similar stocks, and the themes it fits). In Walnut you can ask its AI about GL against your real portfolio and see your actual exposure before deciding.
The bottom line on GL
The bottom line: GL's story right now is Premium growth across agency divisions, with revenue (ttm) at ~$6.0B. If you believe that narrative continues, the call is about sizing GL sensibly and checking overlap with what you own; if you doubt it (the risk: reputational and legal exposure is the defining risk: the 2024 Fuzzy Panda short report alleged systemic insurance fraud (policies for deceased or fictitious people, forged signatures, unauthorized withdrawals) concentrated in agents at American Income Life, and shareholder and derivative lawsuits alleging the company misled investors remain ongoing even after the DOJ probe closed without action.), it is not for you. Decide from the thesis, not the ticker. Walnut is not an investment adviser.
Build a basket around GL with Walnut
Use GL as one constituent in a thematic basket Walnut's AI helps you assemble. Describe a thesis you believe in, the AI proposes the holdings and weights, and you approve before any broker order.
FAQ
Is GL a good stock to buy right now?
+
The case for GL right now is Premium growth across agency divisions, with revenue (ttm) at ~$6.0B. If you believe that thesis holds, GL is a way to own it and the real questions are sizing and overlap, not timing; the main risk to that view is reputational and legal exposure is the defining risk: the 2024 Fuzzy Panda short report alleged systemic insurance fraud (policies for deceased or fictitious people, forged signatures, unauthorized withdrawals) concentrated in agents at American Income Life, and shareholder and derivative lawsuits alleging the company misled investors remain ongoing even after the DOJ probe closed without action. So it comes down to whether you believe the thesis. Walnut is not an investment adviser and this is not a recommendation.
What does GL do?
+
Globe Life Inc.
What are the main risks of GL?
+
Reputational and legal exposure is the defining risk: the 2024 Fuzzy Panda short report alleged systemic insurance fraud (policies for deceased or fictitious people, forged signatures, unauthorized withdrawals) concentrated in agents at American Income Life, and shareholder and derivative lawsuits alleging the company misled investors remain ongoing even after the DOJ probe closed without action. The captive and exclusive agency distribution model concentrates sales in third-party agencies whose conduct the company must police, creating continued regulatory and headline risk. As a life and health insurer, GL is also exposed to interest-rate and credit risk on its large investment portfolio, mortality and morbidity experience, and reserve-adequacy assumptions. Any renewed regulatory inquiry or adverse litigation outcome could pressure the stock, and the middle-income customer base can be sensitive to economic stress and policy lapse.
What does Globe Life do?
+
Globe Life is a US insurance holding company that underwrites individual life insurance and supplemental health insurance for lower-to-middle-income families, selling through captive and exclusive agencies such as American Income Life and Liberty National plus a direct-to-consumer channel.
Is Globe Life a real, established company?
+
Yes. GL is an S&P 500 constituent (formerly Torchmark Corporation) with roughly $6 billion in annual revenue, a market capitalization near $14 billion, and a large in-force book of policies. It is a long-standing, profitable insurer, not a shell or speculative listing.
What were the Fuzzy Panda short-seller allegations?
+
In April 2024 short-seller Fuzzy Panda Research alleged widespread insurance fraud tied to agents at American Income Life, including policies written for deceased or fictitious people and unauthorized withdrawals. The report cut the stock roughly in half in a single day, though the company disputed the claims.
What happened with the DOJ investigation?
+
The US Attorney's Office for the Western District of Pennsylvania investigated Globe Life and American Income Life's sales practices and closed its investigation in July 2025 without taking enforcement action against the company. Some shareholder lawsuits alleging the company misled investors have continued separately.
Walnut is informational and is not an investment adviser. This page is educational and not a recommendation to buy or sell GL; figures are approximate and dated, and your own situation, time horizon, and risk tolerance should drive any decision. Verify current data before investing.